ESC Premium Access

Preventive effects of novel urotensin II receptor antagonist in experimental pulmonary arterial hypertension

Congress Presentation

About the speaker

Doctor Byung Ho Lee

Korea Research Institute of Chemical Technology, Daejeon (Korea (Republic of))
0 follower

6 more presentations in this session

A new experimental model of pulmonary arterial hypertension- KDR knock out

Speaker: Doctor M. Winter (Vienna, AT)

Thumbnail

Hypoxia induces the downregulation of the BMP signalling in pulmonary artery smooth muscle cells through the endothelin system

Speaker: Doctor H. Maruyama (Tsuchiura, JP)

Thumbnail

Hemodynamic and anti-remodelling effect of the rho kinase inhibitor y-27632 in monocrotaline pulmonary arterial hypertension rat model

Speaker: Doctor S. Cantoni (Parma, IT)

Thumbnail

Hypoxia-induced pulmonary hypertension is attenuated by hypoxia-inducible factor-1 alpha deletion in macrophage

Speaker: Mr H. Kojima (Fukuoka, JP)

Thumbnail

Levosimendan prevents and reverts pressure-overload induced right ventricular failure.

Speaker: Miss M. Hansen (Aarhus, DK)

Thumbnail

Access the full session

Basic mechanisms in pulmonary hypertension

Speakers: Doctor B. Lee, Doctor M. Winter, Doctor H. Maruyama, Doctor S. Cantoni, Mr H. Kojima...
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb